ViSPad Supportive Care Study for Brain Tumor Patients

ViSPad Supportive Care Study for Brain Tumor Patients

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).

Who Can Participate?

Eligibility

Adults ages 18+ who:
  • Are scheduled to have MRI scans
  • Have a histological (a microscopic study of the structure of a tumor) diagnosis of primary or metastatic brain tumor
  • Are able to speak, read, and write in English
For more information about who can be in this study, please contact the study team at 919-684-5301.

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

If you chose to be in this study, you will:
  • Complete a Hospital Anxiety and Depression Scale (HADS) questionnaire before your first MRI scan
  • Complete ViSPad (a series of images viewed on an electronic tablet) before your second MRI scan
  • Complete HADS after ViSPad and before your second MRI scan
  • Complete an Exit Survey after your second MRI scan

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

A Feasibility Study for Heavy Compression Static Images (ViSPad) for the Reduction of Anxiety, Depression, and Intrusive Memories in Brain Tumor Patients Undergoing Standard of Care Imaging

Principal Investigator

Katherine
Peters

Protocol Number

PRO00110745

Phase

Pilot

Enrollment Status

Open to Enrollment